Bronchoconstrictor drugs.
D000319:Adrenergic beta-Antagonists / Q000494:pharmacology; D000402:Airway Obstruction / Q000503:physiopathology; D000403:Airway Resistance / Q000187:drug effects*; D000706:Anaphylatoxins / Q000494:pharmacology; D000758:Anesthesia; D000804:Angiotensin II / Q000494:pharmacology; D000818:Animals; D001920:Bradykinin / Q000494:pharmacology; D001980:Bronchi / Q000187:drug effects / Q000294:innervation; D003165:Complement System Proteins / Q000494:pharmacology; D005340:Fibrinogen / Q000494:pharmacology; D006632:Histamine / Q000494:pharmacology; D006801:Humans; D008670:Metals / Q000494:pharmacology; D009119:Muscle Contraction / Q000187:drug effects; D009130:Muscle, Smooth / Q000187:drug effects; D018377:Neurotransmitter Agents / Q000502:physiology; D004364:Pharmaceutical Preparations / Q000378:metabolism; D011453:Prostaglandins / Q000494:pharmacology; D011950:Receptors, Cholinergic / Q000187:drug effects; D011955:Receptors, Drug / Q000187:drug effects; D012018:Reflex / Q000187:drug effects; D012701:Serotonin / Q000494:pharmacology; D013045:Species Specificity; D013565:Sympatholytics / Q000494:pharmacology
D000319:Adrenergic beta-Antagonists; D000706:Anaphylatoxins; D008670:Metals; D018377:Neurotransmitter Agents; D004364:Pharmaceutical Preparations; D011453:Prostaglandins; D011950:Receptors, Cholinergic; D011955:Receptors, Drug; D013565:Sympatholytics; D000804:Angiotensin II; D012701:Serotonin; D006632:Histamine; D005340:Fibrinogen; D003165:Complement System Proteins; D001920:Bradykinin